Institutional investors purchased a net $1.4 million shares of ABBV during the quarter ended June 2014 and now own 70.74% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
IRONBRIDGE CAPITAL MANAGEMENT LP Bought 1.1 Million shares of AbbVie Inc